EIT-labelled International Master of Innovative Medicine
Creating marketable new solutions to transform healthcare requires abilities in life sciences, entrepreneurship and innovation. EIT Health’s IMIM programme focuses on all three of these fields.
The International Master in Innovative Medicine (IMIM) is a multi-disciplinary programme that seeks to attract applicants from different backgrounds who have an excellent academic record and a passion for translational biomedical research. The two-year programme complements bimolecular life science studies with intensive training in entrepreneurship and innovation, and focuses on the education of tomorrow’s leading translational biomedical researchers.
Registration for the fall 2021 semester is open until 15 January 2021.
Learning from two or more institutions
IMIM students are trained by at least two of the three EU partners: the University of Groningen (The Netherlands), Ruprecht-Karls-Universtiät Heidelberg (Germany) and Uppsala Universitet (Sweden). Students will attend both a Spring school dedicated to the development of soft skills and a Summer school focused on private sector priorities and the societal impact of their research.
Who should apply
Applicants should have a bachelor’s degree in one of the following fields: biochemistry; pharmaceutical sciences; biomedical sciences; genetics; molecular biology; biotechnology; medicine; dentistry; or a related discipline.
EIT Label and Erasmus recognition
IMIM provides 120 European Credit Transfer and Accumulation System credits and has earned the EIT Label, a certificate of quality for master’s and doctoral programmes that combine excellent scientific education with innovation and entrepreneurship training. EIT-labelled degrees encourage innovative pedagogies and incorporate mobility schemes involving multiple institutions, to help students form the next generation of health innovators.
IMIM is also an Erasmus+ programme and has been awarded the Erasmus Mundus Joint Master Degree programme (EMJMD) excellence label in 2015 and in 2019.
How to apply
Apply before 15 January 2021 on the IMIM online application system. Find out more about the programme and the application process at https://www.innovativemedicine.eu/
Partners
CLC/InnoStars: Germany
Partner classification: Education, Research, Tech Transfer, Clusters, Other NGOs, Hospital / University Hospital
Partner type: Core Partner
As a comprehensive university, Heidelberg offers, in collaboration with its university hospital, a fertile ground for innovations in the different action fields of healthy living & active ageing by drawing on insights from all academic disciplines.
Heidelberg University
Heidelberg University, Seminarstraße 2, 69117 Heidelberg, Germany
Key Activities in Research and Developement
Biomedical engineering, Life Sciences, Social sciences / health economics, Clinical research
Key Activities in Social Innovation
Healthcare provision, Payers
Key Activities in Business Creation
Incubation, Technology Transfer
Key Activities in Education
Entrepreneurship training, Technical faculties, Medical faculties, Healthcare professional education/training
CLC/InnoStars: Belgium-Netherlands
Partner classification: Business, Education, Hospital / University Hospital
Partner type: Core Partner
The UMCG is a large university medical center focused on patient care, education, research and innovation aiming at societal impact and economic growth. The UMCG focuses on healthy ageing in all priority areas: research, clinical care and education.
University Medical Center Groningen (UMCG)
University Medical Center Groningen (UMCG), Hanzeplein 1, 9713 GZ Groningen, Netherlands
CLC/InnoStars: Scandinavia
Partner classification: Education, Research, Tech Transfer, Clusters, Other NGOs
Partner type: Core Partner
The first university established in the Nordic countries founded in 1477, is an international research university. Uppsala University is ranked #61 in the Academic Ranking of World Universities 2014. World-class research and high at UU benefit society and business on a global level. The University is characterized by diversity and breadth, with international frontline research at nine faculties including 40,000 students, 1,800 teachers and researchers whereof about 670 professors. Comprehensive peer reviews and university rankings consistently show that research at UU is of the highest international standard. Research, education and innovation serve as guiding concepts in connection with cooperation with the business community and society at large
Key Activities in Corporate Innovation
Pharma, Med Tech, ICT, Diagnostics, Imaging
Key Activities in Social Innovation
Healthcare provision
Key Activities in Business Creation
Incubation, Technology Transfer, Business coaching, Testing & Validation
Key Activities in Education
Business Schools, Entrepreneurship training, Technical faculties, Medical faculties, Healthcare professional education/training
CLC/InnoStars: Belgium-Netherlands
Partner classification: Education
Partner type: Linked/Affiliated Party
Rijksuniversiteit Groningen
Rijksuniversiteit Groningen, 9712 CP Groningen, Netherlands